GLP-1 receptor agonists like semaglutide and tirzepatide suppress appetite by increasing feelings of fullness, which can make eating adequate protein challenging for patients on active therapy
Ideal for individuals seeking deeper support for gut healing, immune balance, and recovery from dietary or lifestyle stressors
A weight loss plateau can last anywhere from a few weeks to several months, depending on factors like metabolism, body composition, and overall health
Both drugs share similar gastrointestinal side effects, and both carry boxed warnings related to thyroid cancer risk and MEN2
Liver Effects: In HIV-associated NAFLD, tesamorelin reduces liver fat and attenuates fibrosis progression, supported by transcriptomic downregulation of fibrotic and inflammatory gene pathways
This titration schedule helps minimise gastrointestinal side effects, which are common during initiation